HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -42.9% | 6,966 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $7,000 | -30.0% | 6,966 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $10,000 | -73.7% | 6,966 | 0.0% | 0.01% | -70.8% |
| Q4 2021 | $38,000 | -5.0% | 6,966 | 0.0% | 0.02% | -17.2% |
| Q3 2021 | $40,000 | 0.0% | 6,966 | 0.0% | 0.03% | 0.0% |
| Q2 2021 | $40,000 | +5.3% | 6,966 | 0.0% | 0.03% | -3.3% |
| Q1 2021 | $38,000 | +18.8% | 6,966 | +4.5% | 0.03% | +11.1% |
| Q4 2020 | $32,000 | – | 6,666 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 381,713 | $1,828,000 | 1.56% |
| Cowen Prime Services LLC | 441,918 | $2,117,000 | 0.94% |
| Nantahala Capital Management | 363,622 | $1,742,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 45,221 | $217,000 | 0.04% |
| HighMark Wealth Management LLC | 6,666 | $32,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 10,572 | $51,000 | 0.00% |
| Qube Research & Technologies Ltd | 12,034 | $58,000 | 0.00% |
| Squarepoint Ops LLC | 25,597 | $123,000 | 0.00% |
| Ironwood Financial, llc | 103 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 24 | $0 | 0.00% |